Cargando…
Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis
Pristimerin (Pris) is bioactive natural quinonoid triterpene that has anti-inflammatory and anti-cancer activities. Meanwhile, its effect against hepatitis needs to be elucidated. This investigation aimed to evaluate the ability of Pris to protect against autoimmune hepatitis (AIH). A mouse model of...
Autores principales: | El-Agamy, Dina S., Shaaban, Ahmed A., Almaramhy, Hamdi H., Elkablawy, Sarah, Elkablawy, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883828/ https://www.ncbi.nlm.nih.gov/pubmed/29643811 http://dx.doi.org/10.3389/fphar.2018.00292 |
Ejemplares similares
-
Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways
por: El-Agamy, Dina S, et al.
Publicado: (2018) -
Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity
por: Abo-Haded, Hany M., et al.
Publicado: (2017) -
Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
por: Li, Jia-jun, et al.
Publicado: (2019) -
Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
por: Qi, Dahu, et al.
Publicado: (2021) -
Clinicopathological and prognostic significance of androgen receptor overexpression in colorectal cancer: Experience from Al-Madinah Al-Munawarah, Saudi Arabia
por: Albasri, Abdulkader M., et al.
Publicado: (2019)